Andrew Fein Analyst Performance

Andrew Fein is a stock analyst at HC Wainwright focused in the medical sector, covering 75 publicly traded companies. Over the past year, Andrew Fein has issued 93 stock ratings, including buy and hold recommendations. While full access to Andrew Fein's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Andrew Fein's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Analyst Ranking

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

335 Last 10 Years

Buy Recommendations

93.94% 310 Buy Ratings

Companies Covered

75 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	93.9%	310 ratings
Hold	6.1%	20 ratings
Sell	0.0%	0 ratings

Out of 330 total stock ratings issued by Andrew Fein at HC Wainwright, the majority (93.9%) have been Buy recommendations, followed by 6.1% Hold.

Best & Worst Calls

• Best Call

  000000.0%

  CPXX

  Jun 2015

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.
• Worst Call

  000.0%

  CRTX

  Oct 2021

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	92.0% of companies on NASDAQ	69 companies
NYSE	2.7% of companies on NYSE	2 companies
OTCMKTS	2.7% of companies on OTCMKTS	2 companies
TSE	1.3% of companies on TSE	1 company
NYSEAMERICAN	1.3% of companies on NYSEAMERICAN	1 company

Andrew Fein, an analyst at HC Wainwright, currently covers 75 companies listed on NASDAQ, NYSE, OTCMKTS, TSE and NYSEAMERICAN, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 71 companies	94.7%
	Miscellaneous 2 companies	2.7%
	Basic Materials 1 company	1.3%
	Aerospace 1 company	1.3%

Andrew Fein of HC Wainwright specializes in stock coverage within the Medical sector, with additional focus on and Basic Materials companies.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 38 companies	50.7%
PHARMACEUTICAL PREPARATIONS 15 companies	20.0%
MED - DRUGS 12 companies	16.0%
BIOTECHNOLOGY 3 companies	4.0%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC 3 companies	4.0%
Miscellaneous 2 companies	2.7%
MISCELLANEOUS CHEMICAL PRODUCTS 1 company	1.3%
AEROSP/DEF EQ 1 company	1.3%

About Andrew Fein

Mr. Fein is a Managing Director of Equity Research at H.C. Wainwright. Mr. Fein conducted more than twelve years of biotechnology equity research. Prior to joining H.C. Wainwright, Mr. Fein worked as the Head of the Healthcare Research effort at Chardan Capital Markets. Mr. Fein began his career at J.P. Morgan H&Q and first gained recognition as a Senior Analyst at Leerink Swann. After that, Mr. Fein worked as a Managing Director/Senior Biotechnology Analyst at Jefferies, Piper Jaffray and Collins Stewart. Mr. Fein has received numerous honorable mentions from the Institutional Investor All-America Research poll. Mr. Fein’s educational background includes a Bachelor of Arts degree from Yale University.

Follow on LinkedIn

Andrew Fein's Ratings History at HC Wainwright

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
UTHR United Therapeutics	9/5/2025	Boost Price Target	$380.47	$500.00	Buy	$0.00 00.00% ROI
BIIB Biogen	8/1/2025	Boost Price Target	$128.00	$194.00	Buy	$0.00 00.00% ROI
UTHR United Therapeutics	7/31/2025	Set Price Target	$281.95	$400.00	Buy	$0.00 00.00% ROI
FULC Fulcrum Therapeutics	7/29/2025	Upgrade	$7.65	$12.00	Buy	$0.00 00.00% ROI
KALV KalVista Pharmaceuticals	7/8/2025	Boost Price Target	$15.06	$27.00	Buy	$0.00 00.00% ROI
CADL Candel Therapeutics	6/30/2025	Upgrade	$4.90	$23.00	Buy	$0.00 00.00% ROI
BIIB Biogen	6/26/2025	Reiterated Rating	$127.31	$187.00	Buy	$0.00 00.00% ROI
ACAD ACADIA Pharmaceuticals	6/26/2025	Reiterated Rating	$22.50	$32.00	Buy	$0.00 00.00% ROI
KYMR Kymera Therapeutics	6/26/2025	Reiterated Rating	$46.47	$60.00	Buy	$0.00 00.00% ROI
VRTX Vertex Pharmaceuticals	6/23/2025	Reiterated Rating	$440.87	$550.00	Buy	$0.00 00.00% ROI
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
INSM Insmed	6/11/2025	Boost Price Target	$90.93	$120.00	Buy	$0.00 00.00% ROI
ARVN Arvinas	6/2/2025	Set Price Target	$7.51	$24.00		$0.00 00.00% ROI
SVRA Savara	5/29/2025	Downgrade	$2.14	$2.00	Neutral	$0.00 00.00% ROI
PEPG PepGen	5/29/2025	Lower Price Target	$1.58	$8.00	Buy	$0.00 00.00% ROI
LQDA Liquidia Technologies	5/28/2025	Boost Price Target	$15.60	$35.00	Buy	$0.00 00.00% ROI
PRTA Prothena	5/27/2025	Lower Price Target	$6.58	$14.00	Buy	$0.00 00.00% ROI
VIGL Vigil Neuroscience	5/27/2025	Downgrade	$7.89	$8.00	Neutral	$0.00 00.00% ROI
ACAD ACADIA Pharmaceuticals	5/19/2025	Boost Price Target	$22.26	$32.00	Buy	$0.00 00.00% ROI
ANNX Annexon	5/14/2025	Lower Price Target	$1.75	$14.00	Buy	$0.00 00.00% ROI
STOK Stoke Therapeutics	5/14/2025	Lower Price Target	$8.90	$35.00	Buy	$0.00 00.00% ROI
INSM Insmed	5/12/2025	Reiterated Rating	$65.08	$90.00	Buy	$0.00 00.00% ROI
LQDA Liquidia Technologies	5/12/2025	Reiterated Rating	$15.32	$29.00	Buy	$0.00 00.00% ROI
DYN Dyne Therapeutics	5/9/2025	Lower Price Target	$11.32	$38.00	Buy	$0.00 00.00% ROI
AMLX Amylyx Pharmaceuticals	5/9/2025	Boost Price Target	$4.65	$16.00	Buy	$0.00 00.00% ROI
PEPG PepGen	5/9/2025	Lower Price Target	$1.58	$14.00	Buy	$0.00 00.00% ROI
PRTA Prothena	5/9/2025	Lower Price Target	$7.43	$30.00	Buy	$0.00 00.00% ROI
ALEC Alector	5/9/2025	Boost Price Target	$1.11	$10.00	Buy	$0.00 00.00% ROI
KROS Keros Therapeutics	5/8/2025	Lower Price Target	$13.68	$25.00	Buy	$0.00 00.00% ROI
DNLI Denali Therapeutics	5/7/2025	Lower Price Target	$13.55	$32.00	Buy	$0.00 00.00% ROI
BCRX BioCryst Pharmaceuticals	5/6/2025	Reiterated Rating	$11.03	$30.00	Buy	$0.00 00.00% ROI
UTHR United Therapeutics	5/5/2025	Reiterated Rating	$294.60	$425.00	Buy	$0.00 00.00% ROI
DBVT DBV Technologies	5/5/2025	Boost Price Target	$8.95	$16.00	Buy	$0.00 00.00% ROI
BIIB Biogen	5/2/2025	Lower Price Target	$121.39	$187.00	Buy	$0.00 00.00% ROI
ARVN Arvinas	5/2/2025	Lower Price Target	$7.08	$24.00	Buy	$0.00 00.00% ROI
BPMC Blueprint Medicines	5/2/2025	Reiterated Rating	$99.25	$135.00	Buy	$0.00 00.00% ROI
ACIU AC Immune	5/1/2025	Lower Price Target	$1.73	$12.00	Buy	$0.00 00.00% ROI
NBIX Neurocrine Biosciences	4/22/2025	Lower Price Target	$100.68	$168.00	Buy	$0.00 00.00% ROI
INSM Insmed	4/22/2025	Reiterated Rating	$69.51	$90.00	Buy	$0.00 00.00% ROI
ARVN Arvinas	4/7/2025	Reiterated Rating	$6.56	$81.00	Buy	$0.00 00.00% ROI
IMAB I-Mab	4/4/2025	Lower Price Target	$0.73	$7.00	Buy	$0.00 00.00% ROI
ACIU AC Immune	4/3/2025	Reiterated Rating	$1.88	$16.00	Buy	$0.00 00.00% ROI
KROS Keros Therapeutics	4/1/2025	Reiterated Rating	$10.19	$40.00	Buy	$0.00 00.00% ROI
SVRA Savara	3/28/2025	Reiterated Rating	$2.78	$6.00	Buy	$0.00 00.00% ROI
ABOS Acumen Pharmaceuticals	3/28/2025	Lower Price Target	$1.23	$11.00	Buy	$0.00 00.00% ROI
ZNTL Zentalis Pharmaceuticals	3/27/2025	Reiterated Rating	$1.76	$10.00	Buy	$0.00 00.00% ROI
WVE WAVE Life Sciences	3/26/2025	Reiterated Rating	$9.75	$22.00	Buy	$0.00 00.00% ROI
LQDA Liquidia Technologies	3/20/2025	Reiterated Rating	$14.92	$29.00	Buy	$0.00 00.00% ROI
STOK Stoke Therapeutics	3/19/2025	Reiterated Rating	$8.87	$47.00	Buy	$0.00 00.00% ROI
ZNTL Zentalis Pharmaceuticals	3/17/2025	Reiterated Rating	$1.77	$10.00	Buy	$0.00 00.00% ROI
STRO Sutro Biopharma	3/17/2025	Reiterated Rating	$0.81	$2.00	Neutral	$0.00 00.00% ROI
DYN Dyne Therapeutics	3/17/2025	Reiterated Rating	$12.23	$46.00	Buy	$0.00 00.00% ROI
VIGL Vigil Neuroscience	3/14/2025	Lower Price Target	$2.11	$14.00	Buy	$0.00 00.00% ROI
KALV KalVista Pharmaceuticals	3/14/2025	Reiterated Rating	$12.25	$20.00	Buy	$0.00 00.00% ROI
ACIU AC Immune	3/14/2025	Reiterated Rating	$2.30	$16.00	Buy	$0.00 00.00% ROI
PRQR ProQR Therapeutics	3/14/2025	Boost Price Target	$1.74	$12.00	Buy	$0.00 00.00% ROI
ARVN Arvinas	3/11/2025	Reiterated Rating	$8.49	$81.00	Buy	$0.00 00.00% ROI
FHTX Foghorn Therapeutics	3/7/2025	Reiterated Rating	$4.50	$13.00	Buy	$0.00 00.00% ROI
IBRX ImmunityBio	3/6/2025	Initiated Coverage	$3.06	$8.00	Buy	$0.00 00.00% ROI
TARA Protara Therapeutics	3/6/2025	Reiterated Rating	$3.63	$23.00	Buy	$0.00 00.00% ROI
KMDA Kamada	3/6/2025	Reiterated Rating	$7.10	$11.00	Buy	$0.00 00.00% ROI
TCRX TScan Therapeutics	3/6/2025	Reiterated Rating	$1.92	$15.00	Buy	$0.00 00.00% ROI
AMLX Amylyx Pharmaceuticals	3/5/2025	Reiterated Rating	$3.01	$12.00	Buy	$0.00 00.00% ROI
WVE WAVE Life Sciences	3/5/2025	Reiterated Rating	$11.23	$22.00	Buy	$0.00 00.00% ROI
MRUS Merus	3/3/2025	Reiterated Rating	$47.09	$85.00	Buy	$0.00 00.00% ROI
DYN Dyne Therapeutics	2/28/2025	Lower Price Target	$13.17	$46.00	Buy	$0.00 00.00% ROI
KYMR Kymera Therapeutics	2/28/2025	Boost Price Target	$29.98	$60.00	Buy	$0.00 00.00% ROI
DNLI Denali Therapeutics	2/28/2025	Boost Price Target	$18.60	$87.00	Buy	$0.00 00.00% ROI
CPRX Catalyst Pharmaceuticals	2/28/2025	Reiterated Rating	$21.83	$35.00	Buy	$0.00 00.00% ROI
KROS Keros Therapeutics	2/27/2025	Lower Price Target	$10.94	$40.00	Buy	$0.00 00.00% ROI
ALEC Alector	2/27/2025	Reiterated Rating	$1.72	$7.00	Buy	$0.00 00.00% ROI
ACAD ACADIA Pharmaceuticals	2/27/2025	Reiterated Rating	$18.96	$27.00	Buy	$0.00 00.00% ROI
UTHR United Therapeutics	2/27/2025	Reiterated Rating	$318.89	$425.00	Buy	$0.00 00.00% ROI
BCRX BioCryst Pharmaceuticals	2/25/2025	Reiterated Rating	$8.29	$30.00	Buy	$0.00 00.00% ROI
PEPG PepGen	2/24/2025	Reiterated Rating	$2.81	$16.00	Buy	$0.00 00.00% ROI
NBIX Neurocrine Biosciences	2/21/2025	Reiterated Rating	$116.11	$185.00	Buy	$0.00 00.00% ROI
INSM Insmed	2/21/2025	Reiterated Rating	$83.61	$90.00	Buy	$0.00 00.00% ROI
PRTA Prothena	2/21/2025	Reiterated Rating	$15.25	$48.00	Buy	$0.00 00.00% ROI
CRBP Corbus Pharmaceuticals	2/18/2025	Reiterated Rating	$8.51	$75.00	Buy	$0.00 00.00% ROI
STOK Stoke Therapeutics	2/18/2025	Boost Price Target	$9.74	$47.00	Buy	$0.00 00.00% ROI
BPMC Blueprint Medicines	2/14/2025	Reiterated Rating	$95.19	$135.00	Buy	$0.00 00.00% ROI
BIIB Biogen	2/13/2025	Lower Price Target	$133.43	$241.00	Buy	$0.00 00.00% ROI
VRTX Vertex Pharmaceuticals	2/11/2025	Reiterated Rating	$469.97	$550.00	Buy	$0.00 00.00% ROI
CRBP Corbus Pharmaceuticals	2/10/2025	Reiterated Rating	$10.15	$75.00	Buy	$0.00 00.00% ROI
NBIX Neurocrine Biosciences	2/7/2025	Lower Price Target	$150.51	$185.00	Buy	$0.00 00.00% ROI
VRTX Vertex Pharmaceuticals	1/31/2025	Boost Price Target	$438.40	$550.00	Buy	$0.00 00.00% ROI
PEPG PepGen	1/30/2025	Lower Price Target	$1.84	$16.00	Buy	$0.00 00.00% ROI
ZNTL Zentalis Pharmaceuticals	1/29/2025	Lower Price Target	$1.98	$10.00	Buy	$0.00 00.00% ROI
VIGL Vigil Neuroscience	1/23/2025	Reiterated Rating	$2.51	$17.00	Buy	$0.00 00.00% ROI
KMDA Kamada	1/10/2025	Reiterated Rating	$7.32	$11.00	Buy	$0.00 00.00% ROI
CPRX Catalyst Pharmaceuticals	1/10/2025	Boost Price Target	$22.80	$35.00	Buy	$0.00 00.00% ROI
CGON CG Oncology	1/10/2025	Reiterated Rating	$30.24	$75.00	Buy	$0.00 00.00% ROI
DYN Dyne Therapeutics	1/10/2025	Reiterated Rating	$15.68	$55.00	Buy	$0.00 00.00% ROI
AMLX Amylyx Pharmaceuticals	10/18/2024	Reiterated Rating	$3.92	$8.00	Buy	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.